Compugen (CGEN) Cash & Current Investments (2009 - 2026)

Compugen (CGEN) reported Cash & Current Investments of $91.8 million for Q1 2026, up 29.13% on a YoY basis from $71.1 million in Q1 2025, and down 32.71% sequentially from $136.4 million in Q4 2025.

Compugen (CGEN) Cash & Current Investments (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 18 years of Cash & Current Investments data on file, last reported at $91.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 29.13% year-over-year to $91.8 million; the trailing twelve-month figure through Mar 2026 stood at $91.8 million (up 29.13% YoY), and the FY2025 full-year result was $136.4 million, up 71.25% from the prior year.
  • Cash & Current Investments slipped to $91.8 million in Q1 2026, from $136.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $136.4 million in Q4 2025 to a low of $362000.0 in Q4 2022.
  • A 5-year average of $72.2 million and a median of $71.1 million in 2025 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments plunged 99.69% in 2022 and jumped 10657.73% in 2023, its largest moves.
  • Tracing CGEN's Cash & Current Investments over 5 years: stood at $362000.0 in 2022, then jumped by 10657.73% to $38.9 million in 2023, then surged by 104.47% to $79.6 million in 2024, then soared by 71.25% to $136.4 million in 2025, then plunged by 32.71% to $91.8 million in 2026.
  • Business Quant data shows CGEN's Cash & Current Investments at $91.8 million in Q1 2026, $136.4 million in Q4 2025, and $59.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Compugen 224.57 Mn 132.82 Mn 352,000.00 91.75 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 91.75 Mn
Dec 31, 2025 136.36 Mn
Sep 30, 2025 59.36 Mn
Jun 30, 2025 65.00 Mn
Mar 31, 2025 71.06 Mn
Dec 31, 2024 79.63 Mn
Sep 30, 2024 79.57 Mn
Jun 30, 2024 59.32 Mn
Mar 31, 2024 69.05 Mn
Dec 31, 2023 38.94 Mn
Sep 30, 2023 47.78 Mn
Jun 30, 2023 61.98 Mn
Mar 31, 2023 74.32 Mn
Dec 31, 2022 362,000.00
Sep 30, 2022 88.21 Mn
Jun 30, 2022 97.29 Mn
Mar 31, 2022 106.82 Mn
Dec 31, 2021 117.05 Mn
Sep 30, 2021 102.25 Mn
Jun 30, 2021 111.09 Mn